Disclosure Panels Details Page
Colon/Rectal/Anal Cancers Panel - Disclosures as of 08/31/2022
|
Panel Member
(Spouse/Domestic Partner/Dependent) |
Clinical Research Support/Data Safety Monitoring Board | Scientific Advisory Boards, Consultant, or Expert Witness | Promotional Advisory Boards, Consultant, or Speakers Bureau | Employment/ Governing Board, Patent, Equity, or Royalty | Has Attended |
|---|---|---|---|---|---|
| Frankie Algieri | None | None | None | None | ✔ |
| Mahmoud Al-Hawary MD | None | None | None | None | ✔ |
| Nilofer Azad MD | Agios, Inc. Array Atlas Bayer HealthCare Bristol-Myers Squibb Company Celgene Corporation Daiichi- Sankyo Co. Debio Eli Lilly and Company EMD Serono Incyte Corporation Merck & Co., Inc. Taiho Pharmaceuticals Co., Ltd. |
AstraZeneca Pharmaceuticals LP GlaxoSmithKline Incyte Corporation Mirati QED |
None | None | ✔ |
| Al Benson III MD, FACCC, FACP, FASCO | Amgen Inc. Astellas Pharma US, Inc. Boston Scientific Corporation Bristol-Myers Squibb Company Hutchmed ITM Solucin GmbH Merck Sharpe & Dohme Mirati Mirati Therapeutics, Inc. St. Pharm Syncore Taiho Pharmaceuticals Co., Ltd. Tyme Xencor |
Therabionic Apexigen Artemida BioScend Bristol-Myers Squibb Company Grail HalioDx Janssen Oncology Merck Sharpe & Dohme Natera Pfizer Inc./Hospira Inc. TUKYSA Xencor |
None | None | ✔ |
| Marian Birkeland PhD | None | None | None | None | - |
| Yi-Jen Chen MD, PhD | None | None | None | None | ✔ |
| Kristen Ciombor MD | Array Bristol-Myers Squibb Company Calithera Daiichi- Sankyo Co. Genentech, Inc. Incyte Corporation Merck & Co., Inc. Nucana Pfizer Inc. |
Lilly/Loxo Merck & Co., Inc. Personalis Pfizer Inc. Replimune Seattle Genetics, Inc. |
None | None | ✔ |
| Stacey Cohen MD | None | Bayer HealthCare Delcath Expert Connect Guidepoint Helsell Fettermann Isofol Istari Oncology Pfizer Inc. Robins Kaplan Taiho Pharmaceuticals Co., Ltd. |
None | None | ✔ |
| Harry Cooper MD | None | None | None | None | ✔ |
| Eileen Cucinotta | None | None | None | None | ✔ |
| Dustin Deming MD | Aadi Biosciences Arcus Bristol-Myers Squibb Company Curegenix Eli Lilly and Company EMD Serono Genentech, Inc. Ipsen Merck & Co., Inc. Natera Pfizer Inc. Promega Revolution Medicine Seattle Genetics, Inc. STRATA Oncology |
Bayer HealthCare Eli Lilly and Company Pfizer Inc. Promega Seattle Genetics, Inc. |
None | None | ✔ |
| Ignacio Garrido-Laguna MD, PhD | Amgen Inc. Genentech, Inc. GlaxoSmithKline Halozyme, Inc. MedImmune Inc. Navire Novartis Pharmaceuticals Corporation Pfizer Inc. Seattle Genetics, Inc. SOTIO, LLC Tolero Trishula Yingli |
Cancer Study Group Jazz Pharmaceuticals Inc. Kanaph Therapeutics OncXerna |
None | None | ✔ |
| Kristina Gregory MSN, RN, OCN | None | None | None | None | ✔ |
| Jean Grem MD | Processa Pharmaceuticals | None | None | None | ✔ |
| Andrew Gunn MD | Boston Scientific Corporation Penumbra, Inc Varian Medical Systems, Inc. |
BTG Varian Medical Systems, Inc. |
None | None | ✔ |
| Lisa Gurski PhD | None | None | None | None | ✔ |
| Evelyn Handel PharmD, BCOP, BCPS | None | None | None | None | - |
| J. Randolph Hecht MD | A2 Amgen Inc. Astellas Pharma US, Inc. Bold Merck & Co., Inc. TESARO, Inc. Tizona |
Actym Astellas Pharma US, Inc. Exelixis Inc. Gilead Sciences, Inc. Lutris Mirati Notch Rafael |
None | None | ✔ |
| Kyle Herrmann BSN, RN, OCN | None | None | None | None | ✔ |
| Sarah Hoffe MD | Galera, second trial, GRECO-2, pending activation Varian Medical Systems, Inc. ViewRay |
Beyond the White Coat Galera University of South Florida Vit Inc |
MyCareGorithm Rittenhouse Book Distributors |
None | ✔ |
| Joleen Hubbard MD | None | Bayer HealthCare Merck & Co., Inc. |
None | None | ✔ |
| Steven Hunt MD | No commercial interest. This is a lab developed system for photoacoustic imaging of tumors. | None | None | None | ✔ |
| William Jeck MD | None | None | None | None | ✔ |
| Kimberly Johung MD, PhD | None | None | None | None | ✔ |
| Natalie Kirilcuk MD | None | None | None | None | ✔ |
| Smitha Krishnamurthi MD | Aravive Biologics, Inc Bristol-Myers Squibb Company Natera Pfizer Inc. |
None | None | None | ✔ |
| Jennifer Maratt MD | None | None | None | None | ✔ |
| Wells Messersmith MD | Alexo Therapeutics, Inc. Amgen Inc. BeiGene Criterium Exelixis Inc. Experimental Drug Development Centre (Singapore) Fate Therapeutics Gossamer NGM Pfizer Inc. PureTech QED Therapeutics Rascal Therapeutics Zymeworks |
Exelixis Inc. Istari Oncology takeda |
None | None | ✔ |
| Jeffrey Meyerhardt MD, MPH | None | Merck & Co., Inc. | None | None | ✔ |
| Eric Miller MD, PhD | EMD Serono | None | None | None | ✔ |
| Mary Mulcahy MD | None | None | None | None | ✔ |
| Steven Nurkin MD, MS, FACS | None | Merck & Co., Inc. | None | None | ✔ |
| Michael Overman MD | None | None | 3dmed AbbVie, Inc. agilvax Eisai Inc. Gilead Sciences, Inc. gritstone Janssen Pharmaceutica Products, LP Merck & Co., Inc. Novartis Pharmaceuticals Corporation Pfizer Inc. Phanes Takeda Pharmaceuticals North America, Inc. |
uptodate | ✔ |
| Aparna Parikh MD, MS | AbbVie, Inc. Bayer HealthCare Biofidelity Bristol-Myers Squibb Company C2i Checkmate CVS Daiichi- Sankyo Co. Delcath Eli Lilly and Company Foundation Medicine Genentech, Inc. Gennconn biotech Guardant Inivata Mirati Natera Novartis Pharmaceuticals Corporation Pfizer Inc. Plexxikon PMV Pharma Puretech Roche Laboratories, Inc. Seagen Taiho Pharmaceuticals Co., Ltd. Value Analytics Lab |
C2i equity but no valuation yet Xcures XGenomes equity but no valuation yet |
None | None | ✔ |
| Sharon Park PharmD, BCOP | None | None | None | None | ✔ |
| Hitendra Patel MD | None | Epinoma | None | None | ✔ |
| Katrina Pedersen MD, MS | Arcus BioLineRx Boston Biomedical Bristol-Myers Squibb Company Daiichi- Sankyo Co. Incyte Corporation Ipsen MedImmune Inc. Merck & Co., Inc. Natera Nouscom Novartis Pharmaceuticals Corporation Pfizer Inc. Rafael Roche Laboratories, Inc. |
Novartis Pharmaceuticals Corporation Taiho Pharmaceuticals Co., Ltd. |
Pfizer Inc. WebMD/MedScape |
UpToDate | ✔ |
| Donna Powell DHSc, CMD, RT(T) | None | None | None | None | ✔ |
| Leonard Saltz MD | None | Genor Biopharma | None | None | ✔ |
| Charles Schneider MD, FACP | None | None | None | None | ✔ |
| David Shibata MD, FACS, FASCRS | None | None | None | None | ✔ |
| John Skibber MD | None | None | None | None | - |
| Constantinos Sofocleous MD, PhD, FCIRSE, FSIR | Boston Scientific Corporation Ethicon, Inc. Memorial Sloan Kettering IMRAS NIH/NCI SIRTEX Society of Interventional Oncology |
Boston Scientific Corporation Ethicon, Inc. Medtronic, Inc. Varian Medical Systems, Inc. |
None | None | ✔ |
| Katie Stehman MMS, PA-C | None | None | None | None | ✔ |
| Eden Stotsky-Himelfarb BSN, RN | None | None | None | None | - |
| Anna Tavakkoli MD, MSc | None | None | None | None | ✔ |
| Alan Venook MD | Amgen Inc. Bridgebio |
Amgen Inc. Bristol-Myers Squibb Company Exact Sciences Exelixis Inc. Gilead Sciences, Inc. GlaxoSmithKline Merck & Co., Inc. |
None | None | ✔ |
| Erin Vidic | None | None | None | None | - |
| Christopher Willett MD | None | None | None | None | ✔ |